{"entity":{"id":"nct06789679","kind":"trial","name":"Albumin-Bound Paclitaxel and Gemcitabine With or Without S-1 as First-Line Treatment for Advanced Pancreatic Cancer","aka":[],"tldr":"A phase 2 trial in pancreatic cancer, run by Cancer Institute and Hospital, Chinese Academy of Medical Sciences, now recruiting.","summary":"Albumin-Bound Paclitaxel and Gemcitabine With or Without S-1 as First-Line Treatment for Advanced Pancreatic Cancer is a phase 2, randomised interventional study registered as NCT06789679 by Cancer Institute and Hospital, Chinese Academy of Medical Sciences, with a registry enrolment figure of 128 participants, started 2025-01-25 and due to reach its primary completion in 2026-06-30. Interventions recorded: Gemcitabine, albumin-bound paclitaxel, S-1; Gemcitabine, albumin-bound paclitaxel. Conditions listed: Pancreatic Adenocarcinoma. Primary outcome: Objective Response Rate (ORR). Pancreatic eligibility wording from the registry: \"The participant must have a pathological diagnosis of pancreatic ductal adenocarcinoma (including adenosquamous carcinoma)\". Sites: China. No results are recorded here; the registry entry is the source.","status":"recruiting","asOf":"2026-09-24","links":[{"label":"ClinicalTrials.gov NCT06789679","url":"https://clinicaltrials.gov/study/NCT06789679"}],"tags":["ctgov-ingest","pancreatic-deep-dive"],"related":[],"cancers":["locally-advanced-pdac","metastatic-pdac"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT06789679","phase":"2","setting":"Randomized Phase II Clinical Study of Albumin-Bound Paclitaxel and Gemcitabine With or Without S-1 as First-Line Treatment for Locally Advanced or Metastatic Pancreatic Cancer","sponsor":"Cancer Institute and Hospital, Chinese Academy of Medical Sciences","enrolled":128,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct06789679/","neighbours":{"cancer":[{"id":"locally-advanced-pdac","kind":"cancer","name":"Locally advanced unresectable pancreatic ductal adenocarcinoma","route":"/cancers/locally-advanced-pdac/"},{"id":"metastatic-pdac","kind":"cancer","name":"Metastatic pancreatic ductal adenocarcinoma","route":"/cancers/metastatic-pdac/"}],"term":[{"id":"pancreatic-trials-open-today","kind":"term","name":"Pancreatic cancer trials open today (registry snapshot and UK sites)","route":"/terms/pancreatic-trials-open-today/"}]}}